Broadwood Partners challenges STAAR Surgical deal with Alcon
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Broadwood Partners Questions Integrity of STAAR Surgical’s Last-Minute Forecast Change and Fairness Opinion in Sale to Alcon
October 8, 2025 8:00 AM EDTConflicted Management Team Sharply Revised Its Financial Projections Downward Just Days Before Board Vote on Sale to Alcon
Continues to Urge STAAR Shareholders to Vote AGAINST the Proposed Transaction
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today sent the following letter to the shareholders of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common shares, continues to urge its fellow shareholders to vote on its GREEN Proxy Card... More
